|
T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture
|
|
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
|
|
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients
|
|
T2 Biosystems Provides Updates on its New Product Development Pipeline Progress
|
|
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
|
|
T2 Biosystems to Attend Upcoming Investor Conferences
|
|
T2 Biosystems Announces Second Quarter 2024 Financial Results
|
|
T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor
|
|
T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
|
|
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
|